Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$5.86 USD
-1.72 (-22.69%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $5.85 -0.01 (-0.17%) 6:52 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.18 | 0.00% |
Earnings Summary
For their last quarter, Ocular Therapeutix (OCUL) reported earnings of -$0.28 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for OCUL's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 41.94%.
Earnings History
Price & Consensus
Zacks News for OCUL
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 34.74%: Read This Before Placing a Bet
OCUL: What are Zacks experts saying now?
Zacks Private Portfolio Services